Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Return on Equity (ROE) is a vital metric for assessing a company's efficiency in using capital to generate profits. Journey Medical's ROE is 7.5%, below the industry average of 22%, indicating room for improvement. High ROE without excessive debt signifies a good-quality company.